Jason Ekert,
Head US Discovery Translational Technology
Dr. Jason Ekert is Head of US Discovery Translational Technology at UCB. He is responsible for the planning and directing of research, as well as seeking partnerships with research institutions and companies to remain on the leading edge of drug discovery. He’s currently the past chair for the IQ-MPS affiliate and co-leads the regulatory sub-group for the IQ-MPS affiliate. Before joining UCB he was Senior Director, GSK Fellow and Head of the Complex In Vitro Models (CIVM) group at GlaxoSmithKline. He was responsible for an integrated enterprise strategy for R&D applications of complex human-relevant and translatable complex in vitro models (eg Organoids, Microphysiological systems and bioprinting). He worked at Janssen in biotherapeutic drug discovery. Jason received his PhD from Adelaide University. Post-doctoral training was performed at University of California, Davis and Coriell Institute for Medical Research.
|
|
|
